Virtus Peptides supplies GLP-3 (RT) as a lyophilized powder strictly for in-vitro laboratory research
Canadian suppliers offering third-party testing and reliable delivery make this option more accessible for patients facing insurance barriers
If you notice any of the symptoms listed below, get medical help right away, as they could signal a serious or life-threatening problem: Signs of an allergic reaction (e.g., rash, chest tightness, trouble breathing, swelling of the mouth or throat)
Mol Syst Biol
Additional Phase 3 trials are still underway, including TRIUMPH-2 (evaluating retatrutide in adults with obesity and type 2 diabetes) and TRIUMPH-3 (evaluating cardiovascular outcomes), with results expected later in 2026
Medication Options and Costs Providers typically start patients off with a lower dose of GLP-1s to minimize side effects, and this titration is reflected in the pricing